Drugmaker GlaxoSmithKline (GSK) is looking for acquisitions in the Indian market for the first time since it started its operations in the country 93 years ago. "So far, our inorganic growth in India has primarily been driven by global acquisition strategy," India MD Annaswamy Vaidheesh said. He said GSK only recently built a team to evaluate such opportunities in India. 